BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2021 11:58:13 PM | Browse: 791 | Download: 1601
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 64250
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Kai Dai, Yin Wu, Sha She and Qian Zhang
ORCID
Author(s) ORCID Number
Kai Dai http://orcid.org/0000-0001-7270-9965
Yin Wu http://orcid.org/0000-0002-0987-2097
Sha She http://orcid.org/0000-0002-1863-957X
Qian Zhang http://orcid.org/0000-0003-1053-1588
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China (General Program) 81972673
Corresponding Author Kai Dai, MD, PhD, Doctor, Doctor, Department of Infectious Diseases, Renmin Hospital of Wuhan University, No.238,Jie Fang Road,Wuchang District, Wuhan 430060, Hubei Province, China. daikai@whu.edu.cn
Key Words Chimeric antigen receptors; Natural killer cells; Hepatocellular carcinoma; Immunotherapy; Genome engineering
Core Tip Chimeric antigen receptors (CARs)-based immunotherapy is an emerging therapeutic strategy for tumors. This review summarizes the recent advances in genetic engineering of CAR-natural killer (NK) cells against hepatocellular carcinoma and discuss the current challenges and prospects of CAR-NK cells as a revolutionary cellular immunotherapy against hepatocellular carcinoma.
Publish Date 2021-12-14 23:58
Citation Dai K, Wu Y, She S, Zhang Q. Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(12): 2029-2037
URL https://www.wjgnet.com/1948-5204/full/v13/i12/2029.htm
DOI https://dx.doi.org/10.4251/wjgo.v13.i12.2029
Full Article (PDF) WJGO-13-2029.pdf
Full Article (Word) WJGO-13-2029.docx